Z90.1 represents a clinical status indicating the acquired absence of one or both breasts and the associated nipple-areolar complex. This code is most frequently used to document the post-surgical status of a patient who has undergone a mastectomy. Such procedures are typically performed as a definitive treatment for breast malignancy (including invasive ductal or lobular carcinoma and ductal carcinoma in situ), as a prophylactic risk-reduction measure in patients with high-risk genetic mutations (such as BRCA1 or BRCA2), or, less commonly, due to severe trauma or necrotizing infections. As a status code, it is intended to inform the clinical history, guiding surveillance for cancer recurrence, monitoring for post-surgical complications like lymphedema, and facilitating prosthetic or reconstructive planning.
Distinguish between acquired and congenital absence to ensure correct categorization.
Example: Patient presents for follow-up evaluation of the right chest wall status. Documentation: Acquired absence of the right breast and nipple following total mastectomy performed in 2022 for invasive ductal carcinoma. The absence is acquired and not congenital, as noted in the history of prior surgical intervention. This supports Z90.1 laterality and excludes Q83.0.
Billing Focus: Identify the cause as surgical or traumatic to justify the Z90.1 status code over congenital codes.
Explicitly state the laterality of the absence for accurate reporting.
Example: Clinical Note: The patient has a total acquired absence of the left breast and nipple. There is no evidence of local recurrence on the left chest wall. Contralateral right breast is intact. Billing Focus: Left-sided laterality. Risk Adjustment: Captures the specific anatomical loss which impacts future procedural planning such as reconstruction.
Billing Focus: Documentation must specify right, left, or bilateral status to meet coding specificity requirements.
Document the status of the nipple-areola complex specifically.
Example: Evaluation reveals acquired absence of the right breast and right nipple-areola complex (NAC). Patient has not undergone NAC reconstruction. History of TRAM flap reconstruction for the breast mound is noted, but the Z90.1 status remains applicable for the missing nipple. Risk Adjustment: Severity is tracked by identifying if the absence is total or partial.
Billing Focus: Clarification of nipple status alongside the breast tissue ensures Z90.1 is the most appropriate code versus other Z-codes.
Link the absence to the original primary diagnosis or prophylactic reason.
Example: Patient has acquired absence of bilateral breasts and nipples due to bilateral prophylactic mastectomies in 2023 for BRCA1 positive status. No current malignancy. Billing Focus: Links the Z90.1 status to Z15.01 (Genetic susceptibility). Risk Adjustment: Identifies high-risk surgical history which contributes to the overall risk score.
Billing Focus: Associating the status with the reason (malignancy vs. prophylaxis) supports medical necessity for follow-up imaging.
Indicate the presence of breast reconstruction or implants if applicable.
Example: Patient presents with acquired absence of the left breast and nipple; currently has a tissue expander in place. The clinical note details the surgical absence of native tissue. Billing Focus: Distinguishes between native tissue absence and the presence of a prosthetic or reconstructive flap. Risk Adjustment: Reflects the ongoing nature of the surgical episode.
Billing Focus: Ensures coding reflects the transition from total absence to reconstructed status using Z98.82.
Used for routine surveillance visits in patients with acquired absence of the breast where concerns are minimal.
Appropriate for discussing reconstruction options or managing endocrine therapy side effects in a patient with post-mastectomy status.
The primary procedure that results in the diagnosis of Z90.1.
The procedural correction for the nipple absence component of Z90.1.
Commonly performed in patients who currently have the Z90.1 status to restore volume.
Major reconstructive procedure to address the Z90.1 status using the patient's own tissue.
Used for screening the remaining contralateral breast in patients with unilateral acquired absence.
The oncological procedure often resulting in the acquired absence status Z90.1.
The first step in reconstruction for a patient with acquired absence of the breast.
Often performed on the contralateral breast to achieve symmetry with a reconstructed mound following Z90.1.